Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 174 results found. Search for [ Covaxin ]

Results 1 to 21 of 174
BusinessToday.In
October 22, 2020
Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days


BusinessToday.In
October 17, 2020
The shots planned for the initial phase would include a booster dose as well. The list comprises four categories of beneficiaries including frontline workers, healthcare professionals, people above 50, and people with comorbidities


BusinessToday.In
New Delhi, October 15, 2020
As part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half; Bicycle sales in India have grown by over two-folds in the last five months as people are opting for this cheapest mode of transport to cover short to medium distance; Russia on Wednesday announced that it has granted regulatory approval to another COVID-19 vaccine named EpiVacCorona. Watch this and more on News Blast.Also Read: Need to develop more disease-specific health insurance policies: IRDAI


Rashi Bisaria
New Delhi, October 15, 2020
COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...


BusinessToday.In
October 15, 2020
Akhilesh Yadav says he's in constant touch with doctors and that his father's condition is normal; the 80-year-old SP patriarch had earlier reported problems while breathing


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months


BusinessToday.In
October 13, 2020
\"We're expecting that early next year we should have vaccine in the country from maybe more than one source,\" says union health minister Harsh Vardhan


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


PTI
October 10, 2020
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites


BusinessToday.In
October 10, 2020
China was the first to report the outbreak, identified the pathogen and shared the genome sequence with the world, said Chinese Foreign Ministry spokesperson


PTI
October 9, 2020
The death toll climbed to 1,06,490 with 964 people succumbing to the disease in a span of 24 hours


BusinessToday.In
October 9, 2020
Bharat Biotech vaccine: The subject expert committee that discussed the matter in a meeting on October 5 has asked the company to resubmit the protocol and clarify the definition of asymptomatic


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
October 2, 2020
Coronavirus cases in India: The active patients' tally in India stands at 9,42,217; around 53,52,078 patients have recovered and 99,773 have succumbed to the deadly virus so far


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 23, 2020
This inoculation adds to Bharat Biotech's portfolio of vaccines currently being developed by it and are in several stages of clinical development, comprising COVAXIN- which is India's first indigenous vaccine against coronavirus


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


PAGES 1 OF 9  12345